학술논문
P-174 MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma: Trial in progress
Document Type
Abstract
Author
Source
In Annals of Oncology July 2021 32 Supplement 3:S159-S159
Subject
Language
ISSN
0923-7534